{"transactions":[{"id":1138190,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-22T21:04:42.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates."}],"balance_after":180000,"derivative":{"exercise_price":1.34,"expiration_date":"2035-05-20","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0000886744-25-000025","document":"wk-form4_1747947876.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674425000025/wk-form4_1747947876.xml","form_type":"4"}},{"id":1151508,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-13T20:20:43.000Z","date":"2025-05-09","kind":"purchase","planned":false,"acquired":true,"shares":13300,"price":1.178,"value":15667.4,"ownership":{"direct":true},"balance_after":13300,"source":{"system":"sec-edgar","filing":"0000886744-25-000013","document":"wk-form4_1747167635.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674425000013/wk-form4_1747167635.xml","form_type":"4"}},{"id":1512751,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-17T20:05:30.000Z","date":"2024-05-15","kind":"exercise","planned":true,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction reflects an exercise and sale of options due to expire on May 20, 2024, and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on February 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.94,"expiration_date":"2024-05-20","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000950170-24-061615","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024061615/ownership.xml","form_type":"4"}},{"id":1512750,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-17T20:05:30.000Z","date":"2024-05-15","kind":"sale","planned":true,"acquired":false,"shares":35000,"price":3.75,"value":131250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction reflects an exercise and sale of options due to expire on May 20, 2024, and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on February 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.715 to $3.790, inclusive. The reporting person undertakes to provide to Geron Corporation, any security holder of Geron Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-061615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024061615/ownership.xml","form_type":"4"}},{"id":1512749,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-17T20:05:30.000Z","date":"2024-05-15","kind":"exercise","planned":true,"acquired":true,"shares":35000,"price":1.94,"value":67900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction reflects an exercise and sale of options due to expire on May 20, 2024, and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on February 14, 2024."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0000950170-24-061615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024061615/ownership.xml","form_type":"4"}},{"id":1521316,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-10T20:05:12.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the Company through such dates"}],"balance_after":180000,"derivative":{"exercise_price":3.88,"expiration_date":"2034-05-08","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0000950170-24-057795","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024057795/ownership.xml","form_type":"4"}},{"id":1870941,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T23:32:59.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the Company through such dates."}],"balance_after":125000,"derivative":{"exercise_price":3.27,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001062993-23-012815","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323012815/form4.xml","form_type":"4"}},{"id":1880117,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T22:27:17.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":4190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 23, 2023. Price not applicable."}],"balance_after":33140,"source":{"system":"sec-edgar","filing":"0001209191-23-031973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123031973/doc4.xml","form_type":"4"}},{"id":1897312,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-05-12T01:01:25.000Z","date":"2023-05-11","kind":"exercise","planned":true,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction reflects an exercise and sale of options due to expire on May 22, 2023 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.1,"expiration_date":"2023-05-22","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001062993-23-010852","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323010852/form4.xml","form_type":"4"}},{"id":1897311,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-12T01:01:25.000Z","date":"2023-05-11","kind":"sale","planned":true,"acquired":false,"shares":35000,"price":3,"value":105000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction reflects an exercise and sale of options due to expire on May 22, 2023 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 6, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-23-010852","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323010852/form4.xml","form_type":"4"}},{"id":1897310,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-12T01:01:25.000Z","date":"2023-05-11","kind":"exercise","planned":true,"acquired":true,"shares":35000,"price":1.1,"value":38500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction reflects an exercise and sale of options due to expire on May 22, 2023 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 6, 2023."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001062993-23-010852","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323010852/form4.xml","form_type":"4"}},{"id":1929561,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2023-04-04T23:59:34.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on August 29, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":67.81,"exercise_date":"2013-11-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001209191-23-023062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123023062/doc4.xml","form_type":"4"}},{"id":1929560,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T23:59:34.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":8500,"price":97.09,"value":825265.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on August 29, 2022."}],"balance_after":28950,"source":{"system":"sec-edgar","filing":"0001209191-23-023062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123023062/doc4.xml","form_type":"4"}},{"id":1929559,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T23:59:34.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":true,"shares":8500,"price":67.81,"value":576385.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on August 29, 2022."}],"balance_after":37450,"source":{"system":"sec-edgar","filing":"0001209191-23-023062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123023062/doc4.xml","form_type":"4"}},{"id":2237503,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2022-06-09T21:15:38.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":43000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2022, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":43000,"derivative":{"exercise_price":0.73,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":43000},"source":{"system":"sec-edgar","filing":"0001209191-22-035685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247681/000120919122035685/doc4.xml","form_type":"4"}},{"id":2255597,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T01:15:53.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":4980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 24, 2022.  Price not applicable."}],"balance_after":28950,"source":{"system":"sec-edgar","filing":"0001567619-22-011796","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922011796/doc1.xml","form_type":"4"}},{"id":2275414,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-11T22:16:14.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the Company through such dates."}],"balance_after":125000,"derivative":{"exercise_price":1.48,"expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001062993-22-012155","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299322012155/form4.xml","form_type":"4"}},{"id":2295844,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-04-19T00:22:09.000Z","date":"2022-04-14","kind":"exercise","acquired":false,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on July 29, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":37.46,"exercise_date":"2012-11-08","expiration_date":"2022-05-07","underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001567619-22-008633","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922008633/doc1.xml","form_type":"4"}},{"id":2295843,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-19T00:22:09.000Z","date":"2022-04-14","kind":"sale","acquired":false,"shares":4250,"price":83.66,"value":355555.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on July 29, 2021."}],"balance_after":23970,"source":{"system":"sec-edgar","filing":"0001567619-22-008633","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922008633/doc1.xml","form_type":"4"}},{"id":2295842,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-19T00:22:09.000Z","date":"2022-04-14","kind":"exercise","acquired":true,"shares":4250,"price":37.46,"value":159205.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on July 29, 2021."}],"balance_after":28220,"source":{"system":"sec-edgar","filing":"0001567619-22-008633","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922008633/doc1.xml","form_type":"4"}},{"id":2432707,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-01-19T23:34:31.000Z","date":"2022-01-14","kind":"exercise","acquired":false,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on July 29, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":4250,"derivative":{"exercise_price":37.46,"exercise_date":"2012-11-08","expiration_date":"2022-05-07","underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001567619-22-001334","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922001334/doc1.xml","form_type":"4"}},{"id":2432706,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-19T23:34:31.000Z","date":"2022-01-14","kind":"sale","acquired":false,"shares":4250,"price":87.61,"value":372342.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on July 29, 2021."}],"balance_after":23970,"source":{"system":"sec-edgar","filing":"0001567619-22-001334","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922001334/doc1.xml","form_type":"4"}},{"id":2432705,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-19T23:34:31.000Z","date":"2022-01-14","kind":"exercise","acquired":true,"shares":4250,"price":37.46,"value":159205.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on July 29, 2021."}],"balance_after":28220,"source":{"system":"sec-edgar","filing":"0001567619-22-001334","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922001334/doc1.xml","form_type":"4"}},{"id":2675376,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2021-06-09T17:23:50.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2021, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":6.8,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-039226","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247681/000120919121039226/doc4.xml","form_type":"4"}},{"id":2693922,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T23:02:05.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":5120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 25, 2021.  Price not applicable."}],"balance_after":23970,"source":{"system":"sec-edgar","filing":"0001567619-21-011314","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921011314/doc1.xml","form_type":"4"}},{"id":2715353,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-14T01:16:55.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":83000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the Company through such dates."}],"balance_after":83000,"derivative":{"exercise_price":1.39,"expiration_date":"2031-05-10","underlying":"Common Stock","underlying_shares":83000},"source":{"system":"sec-edgar","filing":"0000886744-21-000035","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674421000035/edgar.xml","form_type":"4"}},{"id":2745676,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2021-04-19T20:09:26.000Z","date":"2021-04-15","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on January 16, 2020, as amended on August 21, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":26.49,"exercise_date":"2011-11-12","expiration_date":"2021-05-11","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001567619-21-008291","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921008291/doc1.xml","form_type":"4"}},{"id":2745675,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-19T20:09:26.000Z","date":"2021-04-15","kind":"sale","acquired":false,"shares":7500,"price":76.9,"value":576750.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on January 16, 2020, as amended on August 21, 2020."}],"balance_after":18850,"source":{"system":"sec-edgar","filing":"0001567619-21-008291","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921008291/doc1.xml","form_type":"4"}},{"id":2745674,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-19T20:09:26.000Z","date":"2021-04-15","kind":"exercise","acquired":true,"shares":7500,"price":26.49,"value":198675.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on January 16, 2020, as amended on August 21, 2020."}],"balance_after":26350,"source":{"system":"sec-edgar","filing":"0001567619-21-008291","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921008291/doc1.xml","form_type":"4"}},{"id":2851389,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2021-02-18T23:43:08.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on January 16, 2020, as amended on August 21, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":7500,"derivative":{"exercise_price":26.49,"exercise_date":"2011-11-12","expiration_date":"2021-05-11","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001567619-21-004470","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921004470/doc1.xml","form_type":"4"}},{"id":2851388,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T23:43:08.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":7500,"price":87.41,"value":655575.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on January 16, 2020, as amended on August 21, 2020."}],"balance_after":18850,"source":{"system":"sec-edgar","filing":"0001567619-21-004470","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921004470/doc1.xml","form_type":"4"}},{"id":2851387,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T23:43:08.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":7500,"price":26.49,"value":198675.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on January 16, 2020, as amended on August 21, 2020."}],"balance_after":26350,"source":{"system":"sec-edgar","filing":"0001567619-21-004470","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921004470/doc1.xml","form_type":"4"}},{"id":2908075,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-13T16:25:17.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":17.58,"expiration_date":"2031-01-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-21-000984","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247681/000156761921000984/doc1.xml","form_type":"4"}},{"id":3114484,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2020-06-10T16:24:58.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":28100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2020 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":28100,"derivative":{"exercise_price":8.89,"expiration_date":"2030-06-07","underlying":"Common Stock","underlying_shares":28100},"source":{"system":"sec-edgar","filing":"0001209191-20-035515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247681/000120919120035515/doc4.xml","form_type":"4"}},{"id":3117578,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-09T22:12:40.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":83000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the Company through such dates."}],"balance_after":83000,"derivative":{"exercise_price":1.54,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":83000},"source":{"system":"sec-edgar","filing":"0000886744-20-000049","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674420000049/edgar.xml","form_type":"4"}},{"id":3117168,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T22:04:06.000Z","date":"2020-06-05","kind":"sale","acquired":false,"shares":4430,"price":107.46,"value":476047.8,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on January 16, 2020."}],"balance_after":18850,"source":{"system":"sec-edgar","filing":"0001567619-20-011919","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920011919/doc1.xml","form_type":"4"}},{"id":3131040,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T21:38:03.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 27, 2020. Price not applicable."}],"balance_after":23280,"source":{"system":"sec-edgar","filing":"0001567619-20-011362","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920011362/doc1.xml","form_type":"4"}},{"id":3203080,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2020-03-19T00:46:35.000Z","date":"2020-03-17","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on May 1, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of options outstanding after the transactions from the specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":21.51,"exercise_date":"2010-11-12","expiration_date":"2020-05-11","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001567619-20-006723","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006723/doc1.xml","form_type":"4"}},{"id":3203079,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-19T00:46:35.000Z","date":"2020-03-17","kind":"sale","acquired":false,"shares":3750,"price":75.39,"value":282712.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on May 1, 2019."}],"balance_after":18980,"source":{"system":"sec-edgar","filing":"0001567619-20-006723","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006723/doc1.xml","form_type":"4"}},{"id":3203078,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-19T00:46:35.000Z","date":"2020-03-17","kind":"exercise","acquired":true,"shares":3750,"price":21.51,"value":80662.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on May 1, 2019."}],"balance_after":22730,"source":{"system":"sec-edgar","filing":"0001567619-20-006723","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006723/doc1.xml","form_type":"4"}},{"id":3203077,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-19T00:46:35.000Z","date":"2020-03-16","kind":"sale","acquired":false,"shares":4610,"price":76.52,"value":352757.2,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on January 16, 2020."}],"balance_after":18980,"source":{"system":"sec-edgar","filing":"0001567619-20-006723","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006723/doc1.xml","form_type":"4"}},{"id":3311463,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T17:52:41.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":17.73,"expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-20-001044","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247681/000156761920001044/doc1.xml","form_type":"4"}},{"id":3335371,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2019-12-20T01:09:19.000Z","date":"2019-12-17","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 1, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from the specific stock option grant."}],"balance_after":3750,"derivative":{"exercise_price":21.51,"exercise_date":"2010-11-12","expiration_date":"2020-05-11","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001567619-19-023466","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919023466/doc1.xml","form_type":"4"}},{"id":3335370,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-20T01:09:19.000Z","date":"2019-12-17","kind":"sale","acquired":false,"shares":3750,"price":83.36,"value":312600.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 1, 2019."}],"balance_after":23590,"source":{"system":"sec-edgar","filing":"0001567619-19-023466","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919023466/doc1.xml","form_type":"4"}},{"id":3335369,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-20T01:09:19.000Z","date":"2019-12-17","kind":"exercise","acquired":true,"shares":3750,"price":21.51,"value":80662.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 1, 2019."}],"balance_after":27340,"source":{"system":"sec-edgar","filing":"0001567619-19-023466","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919023466/doc1.xml","form_type":"4"}},{"id":3411142,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2019-09-18T22:47:32.000Z","date":"2019-09-17","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 1, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from the specific stock option grant."}],"balance_after":7500,"derivative":{"exercise_price":21.51,"exercise_date":"2010-11-12","expiration_date":"2020-05-11","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001567619-19-018505","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919018505/doc1.xml","form_type":"4"}},{"id":3411141,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-18T22:47:32.000Z","date":"2019-09-17","kind":"sale","acquired":false,"shares":3750,"price":74.47,"value":279262.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 1, 2019."}],"balance_after":23590,"source":{"system":"sec-edgar","filing":"0001567619-19-018505","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919018505/doc1.xml","form_type":"4"}},{"id":3411140,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-18T22:47:32.000Z","date":"2019-09-17","kind":"exercise","acquired":true,"shares":3750,"price":21.51,"value":80662.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 1, 2019."}],"balance_after":27340,"source":{"system":"sec-edgar","filing":"0001567619-19-018505","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919018505/doc1.xml","form_type":"4"}},{"id":3484913,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2019-06-19T16:27:58.000Z","date":"2019-06-17","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 1, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from the specific stock option grant."}],"balance_after":11250,"derivative":{"exercise_price":21.51,"exercise_date":"2010-11-12","expiration_date":"2020-05-11","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001567619-19-013660","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919013660/doc1.xml","form_type":"4"}},{"id":3484912,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-19T16:27:58.000Z","date":"2019-06-17","kind":"sale","acquired":false,"shares":3750,"price":81.08,"value":304050.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 1, 2019."}],"balance_after":23590,"source":{"system":"sec-edgar","filing":"0001567619-19-013660","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919013660/doc1.xml","form_type":"4"}},{"id":3484911,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-19T16:27:58.000Z","date":"2019-06-17","kind":"exercise","acquired":true,"shares":3750,"price":21.51,"value":80662.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 1, 2019."}],"balance_after":27340,"source":{"system":"sec-edgar","filing":"0001567619-19-013660","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919013660/doc1.xml","form_type":"4"}},{"id":3497893,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-07T23:23:08.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the Company through such dates."}],"balance_after":70000,"derivative":{"exercise_price":1.38,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000886744-19-000062","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674419000062/edgar.xml","form_type":"4"}},{"id":3496918,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-06-07T16:52:12.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":12400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2019 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":12400,"derivative":{"exercise_price":6.33,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":12400},"source":{"system":"sec-edgar","filing":"0001567619-19-013074","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247681/000156761919013074/doc1.xml","form_type":"4"}},{"id":3499214,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-06T22:06:41.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":4430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 4, 2019. Price not applicable."}],"balance_after":23590,"source":{"system":"sec-edgar","filing":"0001567619-19-012972","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919012972/doc1.xml","form_type":"4"}},{"id":3574179,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2019-03-29T22:30:38.000Z","date":"2019-03-27","kind":"exercise","acquired":false,"shares":2150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on June 12, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":14.39,"exercise_date":"2009-11-12","expiration_date":"2019-05-11","underlying":"Common Stock","underlying_shares":2150},"source":{"system":"sec-edgar","filing":"0001567619-19-007874","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919007874/doc1.xml","form_type":"4"}},{"id":3574178,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-29T22:30:38.000Z","date":"2019-03-27","kind":"sale","acquired":false,"shares":2150,"price":89.76,"value":192984.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on June 12, 2018."}],"balance_after":19160,"source":{"system":"sec-edgar","filing":"0001567619-19-007874","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919007874/doc1.xml","form_type":"4"}},{"id":3574177,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-29T22:30:38.000Z","date":"2019-03-27","kind":"exercise","acquired":true,"shares":2150,"price":14.39,"value":30938.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on June 12, 2018."}],"balance_after":21310,"source":{"system":"sec-edgar","filing":"0001567619-19-007874","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919007874/doc1.xml","form_type":"4"}},{"id":3682479,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-30T16:08:19.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":12.37,"expiration_date":"2029-01-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-19-002193","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247681/000089924319002193/doc4.xml","form_type":"4"}},{"id":3716971,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2018-12-28T23:23:14.000Z","date":"2018-12-27","kind":"exercise","acquired":false,"shares":2150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on June 12, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":2150,"derivative":{"exercise_price":14.39,"exercise_date":"2009-11-12","expiration_date":"2019-05-11","underlying":"Common Stock","underlying_shares":2150},"source":{"system":"sec-edgar","filing":"0001567619-18-008811","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918008811/doc1.xml","form_type":"4"}},{"id":3716970,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-28T23:23:14.000Z","date":"2018-12-27","kind":"sale","acquired":false,"shares":2150,"price":82.53,"value":177439.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on June 12, 2018."}],"balance_after":19160,"source":{"system":"sec-edgar","filing":"0001567619-18-008811","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918008811/doc1.xml","form_type":"4"}},{"id":3716969,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-28T23:23:14.000Z","date":"2018-12-27","kind":"exercise","acquired":true,"shares":2150,"price":14.39,"value":30938.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on June 12, 2018."}],"balance_after":21310,"source":{"system":"sec-edgar","filing":"0001567619-18-008811","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918008811/doc1.xml","form_type":"4"}},{"id":3806007,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2018-09-28T23:02:46.000Z","date":"2018-09-27","kind":"exercise","acquired":false,"shares":2150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on June 12, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":4300,"derivative":{"exercise_price":14.39,"exercise_date":"2009-11-12","expiration_date":"2019-05-11","underlying":"Common Stock","underlying_shares":2150},"source":{"system":"sec-edgar","filing":"0001567619-18-003290","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918003290/doc1.xml","form_type":"4"}},{"id":3806006,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-28T23:02:46.000Z","date":"2018-09-27","kind":"sale","acquired":false,"shares":2150,"price":97.93,"value":210549.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on June 12, 2018."}],"balance_after":19160,"source":{"system":"sec-edgar","filing":"0001567619-18-003290","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918003290/doc1.xml","form_type":"4"}},{"id":3806005,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-28T23:02:46.000Z","date":"2018-09-27","kind":"exercise","acquired":true,"shares":2150,"price":14.39,"value":30938.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on June 12, 2018."}],"balance_after":21310,"source":{"system":"sec-edgar","filing":"0001567619-18-003290","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918003290/doc1.xml","form_type":"4"}},{"id":3806491,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2018-09-27T18:00:18.000Z","date":"2018-09-26","kind":"grant","acquired":true,"shares":26033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.778% of the total shares monthly, beginning on October 26, 2018, with 100% of the total shares vested and exercisable on September 26, 2021, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":26033,"derivative":{"exercise_price":15,"expiration_date":"2028-09-25","underlying":"Common Stock","underlying_shares":26033},"source":{"system":"sec-edgar","filing":"0001209191-18-052487","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247681/000120919118052487/doc4.xml","form_type":"4"}},{"id":3866072,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2018-07-17T16:27:02.000Z","date":"2018-07-13","kind":"grant","acquired":true,"shares":36800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 36 equal monthly installments beginning on August 13, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":36800,"derivative":{"exercise_price":8.78,"expiration_date":"2028-07-12","underlying":"Common Stock","underlying_shares":36800},"source":{"system":"sec-edgar","filing":"0001140361-18-032716","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247681/000114036118032716/doc1.xml","form_type":"4"}},{"id":3880665,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2018-06-29T21:59:52.000Z","date":"2018-06-27","kind":"exercise","acquired":false,"shares":2150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on June 12, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":6450,"derivative":{"exercise_price":14.39,"exercise_date":"2009-11-12","expiration_date":"2019-05-11","underlying":"Common Stock","underlying_shares":2150},"source":{"system":"sec-edgar","filing":"0001140361-18-030752","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118030752/doc1.xml","form_type":"4"}},{"id":3880664,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-29T21:59:52.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":2150,"price":93.52,"value":201068.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on June 12, 2018."}],"balance_after":19160,"source":{"system":"sec-edgar","filing":"0001140361-18-030752","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118030752/doc1.xml","form_type":"4"}},{"id":3880663,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-29T21:59:52.000Z","date":"2018-06-27","kind":"exercise","acquired":true,"shares":2150,"price":14.39,"value":30938.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on June 12, 2018."}],"balance_after":21310,"source":{"system":"sec-edgar","filing":"0001140361-18-030752","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118030752/doc1.xml","form_type":"4"}},{"id":3902156,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T00:42:26.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 5, 2018. Price not applicable."}],"balance_after":19160,"source":{"system":"sec-edgar","filing":"0001140361-18-027790","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118027790/doc1.xml","form_type":"4"}},{"id":3929296,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-17T20:45:44.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the company through such dates."}],"balance_after":70000,"derivative":{"exercise_price":3.43,"expiration_date":"2028-05-14","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000886744-18-000034","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674418000034/edgar.xml","form_type":"4"}},{"id":3960263,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2018-04-19T23:19:46.000Z","date":"2018-04-17","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 9, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of stock options outstanding after the transaction from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":38.59,"exercise_date":"2008-11-22","expiration_date":"2018-05-21","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001140361-18-019095","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118019095/doc1.xml","form_type":"4"}},{"id":3960262,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-19T23:19:46.000Z","date":"2018-04-17","kind":"sale","acquired":false,"shares":3750,"price":85,"value":318750.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 9, 2017."}],"balance_after":14860,"source":{"system":"sec-edgar","filing":"0001140361-18-019095","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118019095/doc1.xml","form_type":"4"}},{"id":3960261,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-19T23:19:46.000Z","date":"2018-04-17","kind":"exercise","acquired":true,"shares":3750,"price":38.59,"value":144712.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 9, 2017."}],"balance_after":18610,"source":{"system":"sec-edgar","filing":"0001140361-18-019095","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118019095/doc1.xml","form_type":"4"}},{"id":4075945,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-05T16:07:58.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-18-002888","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247681/000089924318002888/doc4.xml","form_type":"4"}},{"id":4108319,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2018-01-05T01:16:43.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 9, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the number of stock options outstanding after the transaction from this specific stock option grant."}],"balance_after":3750,"derivative":{"exercise_price":38.59,"exercise_date":"2008-11-22","expiration_date":"2018-05-21","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001140361-18-000921","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118000921/doc1.xml","form_type":"4"}},{"id":4108318,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-05T01:16:43.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":3750,"price":88.84,"value":333150.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 9, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"All shares sold at the same price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned has been updated from the reporting person's prior report to exclude 1,050 shares as previously reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017."}],"balance_after":14860,"source":{"system":"sec-edgar","filing":"0001140361-18-000921","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118000921/doc1.xml","form_type":"4"}},{"id":4108317,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-05T01:16:43.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":3750,"price":38.59,"value":144712.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 9, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned has been updated from the reporting person's prior report to exclude 1,050 shares as previously reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017."}],"balance_after":18610,"source":{"system":"sec-edgar","filing":"0001140361-18-000921","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118000921/doc1.xml","form_type":"4"}},{"id":4186885,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-13T23:35:17.000Z","date":"2016-06-06","kind":"other","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 8, 2016, the reporting person filed a Form 4 which inadvertently reported an incorrect total amount of securities beneficially owned following the reported transaction.  This amendment corrects such total."}],"balance_after":13360,"source":{"system":"sec-edgar","filing":"0001140361-17-038676","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117038676/doc1.xml","form_type":"4/A","original_submission_date":"2016-06-08"}},{"id":4206073,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy) Common Stock","published_at":"2017-09-19T19:27:35.000Z","date":"2017-09-15","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 9, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of stock options outstanding after the transaction from this specific stock option grant."}],"balance_after":7500,"derivative":{"exercise_price":38.59,"exercise_date":"2008-11-22","expiration_date":"2018-05-21","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001140361-17-035905","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117035905/doc1.xml","form_type":"4"}},{"id":4206072,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-19T19:27:35.000Z","date":"2017-09-15","kind":"sale","acquired":false,"shares":3750,"price":91.26,"value":342225.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 9, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares sold at the same price."}],"balance_after":15910,"source":{"system":"sec-edgar","filing":"0001140361-17-035905","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117035905/doc1.xml","form_type":"4"}},{"id":4206071,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-19T19:27:35.000Z","date":"2017-09-15","kind":"exercise","acquired":true,"shares":3750,"price":38.59,"value":144712.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 9, 2017."}],"balance_after":19660,"source":{"system":"sec-edgar","filing":"0001140361-17-035905","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117035905/doc1.xml","form_type":"4"}},{"id":4276303,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy) Common Stock","published_at":"2017-06-20T22:31:49.000Z","date":"2017-06-16","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 9, 2017"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of stock options outstanding after the transaction from this specific stock option grant."}],"balance_after":11250,"derivative":{"exercise_price":38.59,"exercise_date":"2008-08-22","expiration_date":"2018-05-21","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001140361-17-025622","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117025622/doc1.xml","form_type":"4"}},{"id":4276302,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-20T22:31:49.000Z","date":"2017-06-16","kind":"sale","acquired":false,"shares":3750,"price":90,"value":337500.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 9, 2017"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares sold at the same price."}],"balance_after":15910,"source":{"system":"sec-edgar","filing":"0001140361-17-025622","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117025622/doc1.xml","form_type":"4"}},{"id":4276301,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-20T22:31:49.000Z","date":"2017-06-16","kind":"exercise","acquired":true,"shares":3750,"price":38.59,"value":144712.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on May 9, 2017"}],"balance_after":19660,"source":{"system":"sec-edgar","filing":"0001140361-17-025622","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117025622/doc1.xml","form_type":"4"}},{"id":4288687,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy) Common Stock","published_at":"2017-06-08T22:32:39.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":4910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests in full on June 6, 2018."}],"balance_after":4910,"derivative":{"exercise_price":89.6,"exercise_date":"2018-06-06","expiration_date":"2027-06-05","underlying":"Common Stock","underlying_shares":4910},"source":{"system":"sec-edgar","filing":"0001140361-17-024514","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117024514/doc1.xml","form_type":"4"}},{"id":4288686,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-08T22:32:39.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":2050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 6, 2017.  Price not applicable."}],"balance_after":15910,"source":{"system":"sec-edgar","filing":"0001140361-17-024514","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117024514/doc1.xml","form_type":"4"}},{"id":4311531,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option\n(Right to Buy)","published_at":"2017-05-19T16:06:20.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from May 17, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":23.8,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-17-013896","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247681/000089924317013896/doc4.xml","form_type":"4"}},{"id":4327207,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-11T00:52:06.000Z","date":"2017-05-09","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the non-employee director's continuous service with the company through such dates."}],"balance_after":50000,"derivative":{"exercise_price":2.63,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000886744-17-000029","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674417000029/edgar.xml","form_type":"4"}},{"id":4410434,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy) Common Stock","published_at":"2017-03-02T23:14:08.000Z","date":"2017-03-01","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan executed on June 6, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Original option grant vests 6/48ths on December 7, 2007, and 1/48th on the 7th day of every month thereafter"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the number of stock options that remain outstanding from this specific stock grant following the reported transaction."}],"balance_after":0,"derivative":{"exercise_price":17.33,"exercise_date":"2007-12-07","expiration_date":"2017-06-06","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001140361-17-010367","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117010367/doc1.xml","form_type":"4"}},{"id":4410433,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-02T23:14:08.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":7500,"price":95,"value":712500.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan executed on June 6, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares were sold at the same price."}],"balance_after":13860,"source":{"system":"sec-edgar","filing":"0001140361-17-010367","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117010367/doc1.xml","form_type":"4"}},{"id":4410432,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-02T23:14:08.000Z","date":"2017-03-01","kind":"exercise","acquired":true,"shares":7500,"price":17.33,"value":129975.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"All shares were sold at the same price."}],"balance_after":21360,"source":{"system":"sec-edgar","filing":"0001140361-17-010367","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117010367/doc1.xml","form_type":"4"}},{"id":4558439,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy) Common Stock","published_at":"2016-11-14T18:59:27.000Z","date":"2016-11-09","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan executed on June 6, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Original option grant vests 6/48ths on December 7, 2007, and 1/48th on the 7th day of every month thereafter"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the number of stock options that remain outstanding from this specific stock grant following the reported transaction."}],"balance_after":7500,"derivative":{"exercise_price":17.33,"exercise_date":"2007-12-07","expiration_date":"2017-06-06","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001140361-16-086257","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036116086257/doc1.xml","form_type":"4"}},{"id":4558438,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-14T18:59:27.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":7500,"price":95,"value":712500.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan executed on June 6, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares were sold at the same price."}],"balance_after":13860,"source":{"system":"sec-edgar","filing":"0001140361-16-086257","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036116086257/doc1.xml","form_type":"4"}},{"id":4558437,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":79433,"kind":"person","name":"LAWLIS V BRYAN","position":1,"cik":"0001247681","reported_name":"LAWLIS V BRYAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-14T18:59:27.000Z","date":"2016-11-09","kind":"exercise","acquired":true,"shares":7500,"price":17.33,"value":129975.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan executed on June 6, 2016."}],"balance_after":21360,"source":{"system":"sec-edgar","filing":"0001140361-16-086257","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036116086257/doc1.xml","form_type":"4"}}]}